Pipette Market Report 2026

The pipette market size has grown steadily in recent years. It will grow from $1.72 billion in 2025 to $1.79 billion in 2026 at a compound annual growth rate (CAGR) of 4%. The growth in the historic period can be attributed to rising demand from pharmaceutical laboratories, growth of biotech research activities, expansion of food and beverage testing labs, increasing adoption in forensic laboratories, development of manual pipette technologies.

The pipette market size is expected to see steady growth in the next few years. It will grow to $2.1 billion in 2030 at a compound annual growth rate (CAGR) of 4%. The growth in the forecast period can be attributed to increasing use of electronic pipettes, adoption in high-throughput pharmaceutical testing, growth in personalized medicine research, rising demand in academic and clinical research, development of multi-channel pipette systems. Major trends in the forecast period include automation of pipette liquid handling processes, integration of electronic pipettes in smart laboratories, iot-enabled pipette monitoring and data logging, ai-powered accuracy optimization in pipetting, cloud-based laboratory workflow management.

The increasing number of clinical trials is expected to drive growth in the pipette market. Clinical trials are research studies designed to assess the safety, effectiveness, and appropriate use of new medical treatments or interventions in human subjects. The rise in clinical trials is being fueled by greater investment in pharmaceutical research and development and the expanding need for innovative therapies. Pipettes play a vital role in these studies by enabling precise and accurate liquid measurement and transfer, which is essential for producing consistent and reliable experimental data. For example, in December 2025, the Association of the British Pharmaceutical Industry reported that the number of clinical trials launched by the pharmaceutical industry in the United Kingdom increased to 578, up from 426 in 2023 - a 35.7% year-over-year rise. Therefore, the growth in clinical trial activity is supporting expansion of the pipette market.

Companies in the pipette industry are developing digital calibration and workflow management tools to enhance accuracy and laboratory efficiency while reducing human error. These digital platforms typically offer features such as automated scheduling, performance monitoring, and standardized operating methods, helping laboratories maintain consistency and regulatory compliance. For instance, in May 2024, Advanced Instruments LLC introduced a major upgrade to its ArtelWare software platform, enabling integration with a variety of single-channel and multichannel pipettes. Designed to support laboratories with higher precision and streamlined processes, the platform allows users to manage calibration records digitally, track pipette performance in real time, and standardize liquid-handling procedures for improved efficiency.

In April 2025, Sartorius AG partnered with LiveLabs to provide early-stage life science startups with essential laboratory tools. The collaboration aims to accelerate research workflows, encourage adoption of advanced technologies, and support reproducible experimentation by offering solutions such as electronic pipettes, live-cell analysis systems, and precision balances. LiveLabs operates as a life science incubator dedicated to helping new biotechnology and life science companies grow and develop.

Major companies operating in the pipette market report are Thermo Fisher Scientific Inc., Corning Incorporated, Avantor Inc., Sartorius AG, Mettler Toledo International Inc., Integra Biosciences AG, Eppendorf AG, Hamilton Company, IKA-Werke GmbH & Co. KG, Gilson Inc., DWK Life Sciences, Accumax Lab Devices Pvt. Ltd., BRAND GMBH + CO KG, AHN Biotechnologie GmbH, Microlit Industries Private Limited, Socorex Isba SA, Kartell S.p.A., OHAUS Corporation, CAPP ApS, Scilogex LLC, Nichiryo Co. Ltd.

North America was the largest region in the pipette market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pipette market are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pipette market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pipette market consists of sales of manual pipette controllers, electronic pipette controllers, pipette tips, and pipette accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.